Advertisement

Metvan, bis(4,7-Dimethyl-1,10-phenanthroline)sulfatooxidovanadium(IV): DFT and Spectroscopic Study—Antitumor Action on Human Bone and Colorectal Cancer Cell Lines

  • Ignacio E. León
  • María C. Ruiz
  • Carlos A. Franca
  • Beatriz S. Parajón-Costa
  • Enrique J. Baran
Article

Abstract

The complex bis(4,7-dimethyl-1,10-phenantroline)sulfatooxidovanadium(IV), commonly known as Metvan, was prepared using a known synthetic procedure. Its optimized molecular structure was obtained by DFT calculations, as it was impossible to grow single crystals adequate for a crystallographic study. The complex was also characterized by a detailed analysis of its infrared spectrum, supported by the theoretical calculations, and also by some data derived from its Raman spectrum. In addition, cytotoxicity studies were performed using human osteosarcoma (MG-63) and human colorectal adenocarcinoma (HT-29) cell lines. The results show that Metvan impaired cell viability of both cancer cell lines in a low concentration range (0.25–5.0 μM).

Keywords

Oxidovanadium(IV) Metvan DFT calculations FTIR spectrum Human bone and colorectal cancer cell lines 

Notes

Funding Information

This research was supported by the Universidad Nacional de La Plata (Projects X/690 and X/673), the Agencia Nacional de Promoción Científica y Tecnológica-ANPCyT (PICT 2014-2223), and the Consejo Nacional de Investigaciones Científicas y Técnicas-CONICET (PIP 0034). IEL and BSPC are members of the Research Career from CONICET; MCR has a fellowship from CONICET.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Evangelou AM (2002) Vanadium in cancer treatment. Crit Rev Oncol Hematol 42:249–265CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Bishayee A, Waghray A, Patel MA, Chatterjee M (2010) Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett 294:1–12CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Rehder D (2013) Vanadium. Its role for humans. In: Sigel A, Sigel H, Sigel RKO (eds) Metal ions in life sciences Vol 13: Interrelation between essential metal ions and human diseases. Springer, Dordrecht, pp 139–169CrossRefGoogle Scholar
  4. 4.
    Köpf-Maier P (1993) Antitumor bis(cyclopentadienyl)metal complexes. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. Verlag Chemie, Weinheim, pp 259–296Google Scholar
  5. 5.
    Köpf-Maier P, Köpf H (1994) Organometallic titaninum, vanadium, niobium, molybdenum and rhenium complexes - early transition metal antitumor drugs. In: Fricker SP (ed) Metal compounds in cancer therapy. Chapman & Hall, London, pp 109–146CrossRefGoogle Scholar
  6. 6.
    Rehder D (2012) The potentiality of vanadium in medicinal applications. Fut Med Chem 4:1823–1837CrossRefGoogle Scholar
  7. 7.
    Costa Pessoa J, Etcheverry SB, Gambino D (2015) Vanadium compounds in medicine. Coord Chem Rev 301/302:24–48CrossRefGoogle Scholar
  8. 8.
    Costa-Pessoa J (2015) Thirty years through vanadium chemistry. J Inorg Biochem 147:4–24CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Leon IE, Cadavid-Vargas JF, Di Virgilio AL, Etcheverry SB (2016) Vanadium, ruthenium and copper compounds: a new class of non-platinum metallodrugs with anticancer activity. Curr Med Chem 23:1–37CrossRefGoogle Scholar
  10. 10.
    Narla RK, Dong Y, Klis D, Uckun FM (2001) Bis (4,7-dimethyl-1,10- phenathroline)sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Clin Cancer Res 7:1094–1101PubMedPubMedCentralGoogle Scholar
  11. 11.
    Narla RK, Chen CL, Dong Y, Uckun FM (2001) In vivo antitumor activity of bis((4,7-dimethyl-1,10-phenathroline)sulfatooxovanadium(IV) {METVAN [VO(SO4)(Me2-Phen)2]}). Clin Cancer Res 7:2124–2133PubMedPubMedCentralGoogle Scholar
  12. 12.
    D’Cruz OJ, Uckun FM (2002) Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity. Expert Opin Investig Drugs 11:1829–1936CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Sanna D, Ugone V, Micera G, Buglyó P, Bíró L, Garribba E (2017) Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug. Dalton Transact 46:8950–8967CrossRefGoogle Scholar
  14. 14.
    Levina A, Crans DC, Lay PA (2017) Speciation on metal drugs, supplements and toxins and bodily fluids controls in vitro activities. Coord Chem Rev 352:473–498CrossRefGoogle Scholar
  15. 15.
    Le M, Rathje O, Levina A, Lay PA (2017) High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium. J Biol Inorg Chem 22:663–672CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Dong Y, Narla RK, Sudbeck E, Uckun FM (2000) Synthesis, X-ray structure, and anti-leukemik activity of oxovanadium(IV) complexes. J Inorg Biochem 78:321–330CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Zhao Y, Truhlar DG (2008) The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals amd 12 other functionals. Theor Chem Accounts 120:215–241CrossRefGoogle Scholar
  19. 19.
    Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JJA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas O, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2010) Gaussian-09. Gaussian Inc., WallingfordGoogle Scholar
  20. 20.
    Weigend F, Ahlrichs R (2005) Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence qualify for H to Rn: design and assessment of accuracy. Phys Chem Chem Phys 7:3297–3305CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Álvarez L, Grirrane A, Moyano R, Álvarez E, Pastor A, Galindo A (2010) Comparison of the coordination capabilities of thiodiacetate and oxydiacetate ligands through the X-ray characterization and DFT studies of [VO(dta)(phen)]·4H2O and [VO(oda)(phen)]·1.5H2O. Polyhedron 29:3028–3035CrossRefGoogle Scholar
  22. 22.
    del Rio D, Galindo A, Vicente R, Mealli C, Ienco A, Mais D (2003) Synthesis, molecular structure and properties of oxo-vanadium(IV) complexes containing the oxydiacetate ligand. Dalton Transact. 2003:1813–1820Google Scholar
  23. 23.
    Altmann W, Perkampus HH (1979) Normalkoordinatenanalyse der Phenanthroline. Teil I. Die planaren Grundschwingungen. Spectrochim Acta 35A:253–257CrossRefGoogle Scholar
  24. 24.
    Altmann W, Kleindienst H, Perkampus HH (1979) Normalkoordinatenana- lyse der Phenanthroline. Teil II. Die out-of-plane Schwingungen. Spectrochim Acta 35A:259–262CrossRefGoogle Scholar
  25. 25.
    Thornton DA, Watkins GM (1991) A full vibrational assignment (4000-50 cm-1) of 1,10-phenanthroline and its perdeuterated analogue. Spectrochim Acta 47A:1085–1096CrossRefGoogle Scholar
  26. 26.
    Reiher M, Brehm G, Schneider S (2004) Assignment of vibrational spectra of 1,10-phenanthroline by comparison with frequencies and Raman intensities from density functional calculations. J Phys Chem A108:734–742CrossRefGoogle Scholar
  27. 27.
    Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG (1991) The handbook of infrared and Raman characteristic frequencies of organic molecules. Academic Press, BostonGoogle Scholar
  28. 28.
    Smith B (1999) Infrared spectral interpretation. CRC-Press, Boca RatonGoogle Scholar
  29. 29.
    Siebert H (1966) Anwendungen der Schwingunsspektroskopie in der Anorganischen Chemie. Springer, BerlinCrossRefGoogle Scholar
  30. 30.
    Schilt AA, Taylor RC (1959) Infrared spectra of 1,10-phenanthroline metal complexes in the rock salt region below 2000 cm-1. J Inorg Nucl Chem 9:211–221CrossRefGoogle Scholar
  31. 31.
    Nakamoto K (1997) Infrared and Raman spectra of inorganic and coordination compounds, 5th edn. J. Wiley, New YorkGoogle Scholar
  32. 32.
    Müller A, Baran EJ, Carter RO (1976) Vibrational spectra of oxo-, thio-, and selenometallates of transition elements in the solid state. Struct Bond 26:81–139CrossRefGoogle Scholar
  33. 33.
    Weinstock N, Schulze H, Müller A (1973) Assignment of ν2 (E) and ν4 (F2) of tetrahedral species by the calculation of the relative Raman intensities: the vibrational spectra of VO4 3-, CrO4 2-, MoO4 2-, WO4 2-, MnO4 -, TcO4 -, ReO4 -, RuO4 and OsO4. J Chem Phys 59:5063–5067CrossRefGoogle Scholar
  34. 34.
    Leon IE, Parajón-Costa BS, Franca CA, Etcheverry SB, Baran EJ (2015) A new oxidovanadium(IV) complex of oxodiacetic acid and dppz: spectroscopic and DFT study. Antitumor action on MG-63 human osteosarcoma cell line. Biol Trace Elem Res 164:198–204CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Benítez J, Guggeri L, Tomaz I, Costa Pessoa J, Moreno V, Lorenzo J, Avilés FX, Garat B, Gambino D (2009) A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and antitumor agent. J Inorg Biochem 103:1386–1394CrossRefPubMedCentralGoogle Scholar
  36. 36.
    Inskep RG (1962) Infrared spectra of metal complex ions below 600 cm-1. J Inorg Nucl Chem 24:763–776CrossRefGoogle Scholar
  37. 37.
    Baran EJ (2008) Vanadium detoxification: chemical and biochemical aspects. Chem Biodivers 5:1475–1484CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Ignacio E. León
    • 1
  • María C. Ruiz
    • 1
  • Carlos A. Franca
    • 1
  • Beatriz S. Parajón-Costa
    • 1
  • Enrique J. Baran
    • 1
  1. 1.Centro de Química Inorgánica (CEQUINOR/CONICET, CICPBA, UNLP), Facultad de Ciencias ExactasUniversidad Nacional de La PlataLa PlataArgentina

Personalised recommendations